These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 7338157

  • 1. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM, Crum CP, Pascal RR, Richart RM.
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [Abstract] [Full Text] [Related]

  • 2. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S, Mesa-Tejada R, Husami N, Bennett S, Richart RM, Fenogolio CM.
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract] [Full Text] [Related]

  • 3. [Plasma fibrinogen in female patients with genital cancer and its early stage].
    Lober R, Krantz S, Lober M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Dec; 112(1):71-81. PubMed ID: 2581873
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R, Caffier H, Horner G, Lang K, Filbry E.
    Cancer Detect Prev; 1985 Dec; 8(1-2):115-20. PubMed ID: 4064031
    [Abstract] [Full Text] [Related]

  • 5. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H, Gleissenberger U.
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum copper alterations in genital cancer.
    O'Leary JA, Feldman M.
    Surg Forum; 1970 Jul; 21():411-2. PubMed ID: 5514783
    [No Abstract] [Full Text] [Related]

  • 11. Tumor and serum CEA content in gynecologic neoplasms.
    Kula J, Richter R, Gawlikowski W, Harłozińska A.
    Neoplasma; 1984 Jul; 31(1):89-93. PubMed ID: 6322027
    [Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
    Khoo SK, Daunter B, Mackay E.
    Int J Gynaecol Obstet; 1979 Jul; 16(5):388-93. PubMed ID: 86469
    [Abstract] [Full Text] [Related]

  • 13. [CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay].
    Hörst M, Wiest W.
    Fortschr Med; 1982 Mar 18; 100(11):482-3. PubMed ID: 7076078
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical markers in gynaecological cancer.
    Farrell RJ.
    Ir Med J; 1980 Aug 18; 73(8):285-6. PubMed ID: 6161106
    [No Abstract] [Full Text] [Related]

  • 15. Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress.
    DiSaia PJ, Morrow CP, Haverback BJ, Dyce BJ.
    Obstet Gynecol; 1976 Jan 18; 47(1):95-9. PubMed ID: 1246404
    [Abstract] [Full Text] [Related]

  • 16. Multiple biochemical markers in patients with gynecologic malignancies.
    Donaldson ES, van Nagell JR, Pursell S, Gay EC, Meeker WR, Kashmiri R, van deVoorde J.
    Cancer; 1980 Mar 01; 45(5):948-53. PubMed ID: 6167342
    [Abstract] [Full Text] [Related]

  • 17. [A case of immunohistochemically carcinoembryonic antigen producing cervical cancer--the evaluation of plasma CEA levels in 201 patients with uterine cancer].
    Yokoyama T, Kaneko H, Kawamura S, Tanaka M, Chiba T, Hiura M, Moriwaki S.
    Gan No Rinsho; 1987 Jul 01; 33(8):975-80. PubMed ID: 3613119
    [Abstract] [Full Text] [Related]

  • 18. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH.
    Adv Anat Pathol; 2007 May 01; 14(3):149-77. PubMed ID: 17452813
    [Abstract] [Full Text] [Related]

  • 19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM.
    Am J Surg Pathol; 2009 Jun 01; 33(6):914-24. PubMed ID: 19295407
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.